New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Elanco Animal Health Incorporated
ELAN
Shape
US Flag

NYSE

6B

Drug Manufacturers - Specialty & Generic

Next Earning date - 24 Feb 2025

6B

Drug Manufacturers - Specialty & Generic

Next Earning date - 24 Feb 2025

12.02USD
Shape0.01 ( 0.08%)
Market Open
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

-24%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

36%

Quote Panel

Shape
Updated January 19, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

ELAN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5B

Shape341%

2025-Revenue

$0.91

Shape23%

2025-EPS

$328M

Shape-58%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

16.00(33.11%)

Number of analyst

2

Last analyst upgrade/downgrade

UBS

initialise

Previous: Not converted

2024-12-09

Now: Buy

Leerink Partners

initialise

Previous: Not converted

2024-12-02

Now: Market Perform

Morgan Stanley

downgrade

Previous: Overweight

2024-09-19

Now: Equal-Weight

Barclays

upgrade

Previous: Equal-Weight

2023-04-20

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-10%

0.19
vs 0.21

Q1.23

arrow
arrow

+25%

0.45
vs 0.36

Q2.23

arrow
arrow

-50%

0.18
vs 0.36

Q3.23

arrow
arrow

-10%

0.18
vs 0.2

Q4.23

arrow
arrow

-58%

0.08
vs 0.19

Q1.24

arrow
arrow

-24%

0.34
vs 0.45

Q2.24

arrow
arrow

+67%

0.3
vs 0.18

Q3.24

arrow
arrow

-28%

0.13
vs 0.18

Q4.24

arrow
arrow

+91%

0.15
vs 0.08

Q1.25

arrow
arrow

-10%

0.31
vs 0.34

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-11%

988M  vs 1.1B

Q1.23

arrow
arrow

+3%

1.3B  vs 1.2B

Q2.23

arrow
arrow

-10%

1.1B  vs 1.2B

Q3.23

arrow
arrow

+4%

1.1B  vs 1B

Q4.23

arrow
arrow

+5%

1B  vs 988M

Q1.24

arrow
arrow

-4%

1.2B  vs 1.3B

Q2.24

arrow
arrow

+12%

1.2B  vs 1.1B

Q3.24

arrow
arrow

-4%

1B  vs 1.1B

Q4.24

arrow
arrow

-2%

1B  vs 1B

Q1.25

arrow
arrow

+1%

1.2B  vs 1.2B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-1%

-0.01
vs -0.01

Q1.23

arrow
arrow

+1%

0.01
vs -0.01

Q2.23

arrow
arrow

-1%

-0.01
vs 0.01

Q3.23

arrow
arrow

-18%

-0.18
vs -0.01

Q4.23

arrow
arrow

-2%

-0.02
vs -0.18

Q1.24

arrow
arrow

+1%

0.01
vs -0.02

Q2.24

arrow
arrow

-1%

-0.01
vs 0.01

Q3.24

arrow
arrow

+6%

0.06
vs -0.01

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

429

429
vs 437

-2%

Q1.23

arrow
arrow

410

410
vs 429

-4%

Q2.23

arrow
arrow

370

370
vs 410

-10%

Q3.23

arrow
arrow

371

371
vs 370

0%

Q4.23

arrow
arrow

374

374
vs 371

1%

Q1.24

arrow
arrow

394

394
vs 374

5%

Q2.24

arrow
arrow

428

428
vs 394

9%

Q3.24

arrow
arrow

413

413
vs 428

-3%

Earnings Growth

Latest News